Page last updated: 2024-12-07

tamiflu

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tamiflu, chemically known as oseltamivir, is a neuraminidase inhibitor used to treat and prevent influenza A and B infections. It works by blocking the activity of the neuraminidase enzyme, which is essential for the release of new influenza virus particles from infected cells. This prevents the spread of the virus within the body. Tamiflu is typically administered orally in capsule or liquid form. It is effective in reducing the duration of flu symptoms and can also help prevent complications such as pneumonia. However, it is most effective when taken early in the course of the illness. Tamiflu is a synthetic compound, meaning it is not naturally occurring and is created in a laboratory. It was first synthesized by the pharmaceutical company Gilead Sciences in the 1990s. Tamiflu is an important antiviral medication because it can help reduce the spread of influenza and prevent serious complications from the virus. It is particularly important in high-risk populations, such as elderly individuals and those with underlying health conditions. Tamiflu is studied extensively to understand its effectiveness in different populations, its potential side effects, and its role in pandemic preparedness. Research is ongoing to develop new antiviral medications that are more effective and have a broader range of activity against different influenza strains.'

Cross-References

ID SourceID
PubMed CID78000
CHEMBL ID1200340
CHEBI ID7799
SCHEMBL ID8730
MeSH IDM0356518

Synonyms (95)

Synonym
HY-17016
oseltamivir (phosphate)
oseltamivir phosphate [usan:usp]
unii-4a3o49ngez
4a3o49ngez ,
nsc 758897
(3r-(3alpha,4beta,5alpha))-ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, phosphate (1:1)
ro-64-0796/002
(3r-(3alpha,4beta,5alpha)-ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
oseltamivir phosphate [usan]
ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
ro 64-0796/002
1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)-, phosphate (1:1)
gs-4104/002
tamiflu
1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r-(3alpha,4beta,5alpha)-, phosphate (1:1)
204255-11-8
oseltamivir phosphate
C08093
tamiflu (tn)
oseltamivir phosphate (jan/usp)
D00900
ebilfumin (tn)
CHEBI:7799 ,
ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate
oseltamiviri phosphas
CHEMBL1200340
ro-64-0796-002
oseltamivir (as phosphate)
(3r,4r,5s)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester phosphate
oseltamir phosphate
(3r,5s)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate;osteltamivir phosphate
A4307
BCP9001033
BCPP000138
oseltamivir phosphate [orange book]
oseltamivir phosphate [usp-rs]
ethyl-(3r,4r,5s)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate
oseltamivir phosphate [who-dd]
oseltamivir phosphate [jan]
(3r-(3.alpha.,4.beta.,5.alpha.))-ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)
oseltamivir phosphate [usp monograph]
oseltamivir phosphate [usp impurity]
oseltamivir phosphate [mi]
oseltamivir phosphate [ep monograph]
oseltamiviri phosphas [who-ip latin]
oseltamivir phosphate [mart.]
oseltamivir phosphate [who-ip]
oseltamivir phosphate [vandf]
CS-0871
AKOS015896056
S2597
phosphoric acid ethyl (3r,4r,5s)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
MLS006011559
smr004703323
SCHEMBL8730
KS-1184
(3r,4r,5s)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphoric acid salt
(3r,4r,5s)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester phosphate
PGZUMBJQJWIWGJ-ONAKXNSWSA-N
DTXSID0044230 ,
AC-25911
ethyl (3r,4r,5s)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid
J-523838
CCG-230250
SR-05000001499-2
oseltamivir phosphate, united states pharmacopeia (usp) reference standard
SR-05000001960-1
sr-05000001960
oseltamivir phosphate (impurity b free), european pharmacopoeia (ep) reference standard
oseltamivir phosphate, >=98% (hplc)
oseltamivir phosphate, pharmaceutical secondary standard; certified reference material
oseltamivir phosphate; ethyl (3r,4r,5s)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylate phosphate
J-013302
Z1541759495
(3r,4r,5s)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate
Q27107588
gs 4104 phosphate
benzofuran-3-yl-(3-boc-amino-azetidin-1-yl)-aceticacid
AMY583
aseltamivir phosphate
ethyl (3r,4r,5s)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; phosphoric acid
EN300-122356
BO164181
c16h31n2o8p
HB7776
dtxcid8024230
oseltamivir phosphate (ep monograph)
oseltamivir phosphate (usp impurity)
oseltamivir phosphate (usp monograph)
oseltamivir phosphate (mart.)
oseltamivir phosphate (usp-rs)
oseltamavir phosphate
oseltamivir phosphate for oral suspension

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" pastoris expressing human, mouse, and rat peptide transporter 1 (PEPT1), in which uptake was examined as a function of time, concentration, potential inhibitors, and the dose-response inhibition of GlySar by oseltamivir."( Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
Chen, X; Hu, Y; Smith, DE, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphate salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)133.00000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)133.00000.20005.677410.0000AID1473741
Bile salt export pumpHomo sapiens (human)IC50 (µMol)133.00000.11007.190310.0000AID1473738
NeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))Ki0.86000.01000.43500.8600AID1545070
Solute carrier family 15 member 1Homo sapiens (human)IC50 (µMol)27,400.00000.18000.19000.2000AID1222578
Neuraminidase Influenza A virus (A/RI/5+/1957(H2N2))IC50 (µMol)0.80000.80001.76673.1000AID1129834
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (48)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
viral release from host cellNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
monoatomic ion transportSolute carrier family 15 member 1Homo sapiens (human)
protein transportSolute carrier family 15 member 1Homo sapiens (human)
peptide transportSolute carrier family 15 member 1Homo sapiens (human)
dipeptide import across plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
tripeptide import across plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
proton transmembrane transportSolute carrier family 15 member 1Homo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
exo-alpha-sialidase activityNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
peptidase activator activityNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
proton-dependent oligopeptide secondary active transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
peptide:proton symporter activitySolute carrier family 15 member 1Homo sapiens (human)
tripeptide transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
dipeptide transmembrane transporter activitySolute carrier family 15 member 1Homo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
extracellular regionNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
plasma membraneNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
brush borderSolute carrier family 15 member 1Homo sapiens (human)
membraneSolute carrier family 15 member 1Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
apical plasma membraneSolute carrier family 15 member 1Homo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (140)

Assay IDTitleYearJournalArticle
AID1820898Antiviral activity against Influenza A virus A/Puerto Rico/8/34(H1N1) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID1222581Drug uptake in Pichia pastoris GS115 expressing human recombinant PEPT1 at 5 uM after 0.5 to 5 mins by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531360Apparent oral clearance in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525092Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 11 mg/kg, po for 12 hrs post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID524866Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered qd post 13 hrs infection measured after 37 hrs p2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1565064Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus A/WSN/332019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID1637793Selectivity index, ratio of CC50 for MDCK cells to EC50 for amantadine-sensitive Influenza A virus (A/chicken/Hubei/327/2004(H5N1))2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID1565061Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID531364Cmax in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531363Ratio of AUC (0 to last) in healthy adult CSF to AUC (0 to last) in healthy adult plasma at 150 mg, po administered as single dose2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1610463Antiviral activity against oseltamivir resistant Yamagata lineage of Influenza B virus (B/Massachusetts/2/2012) BX-51B infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence ass2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
AID531366Tmax in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1222588Stability in Pichia pastoris GS115 expressing mouse recombinant PEPT1 at 5 uM measured for up to 30 mins by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID525090Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 11 mg/kg, po for 4 days post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1222587Stability in Pichia pastoris GS115 expressing human recombinant PEPT1 at 5 uM measured for up to 30 mins by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531367Tmax in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1180482Antiviral activity against Influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as inhibition of virus-induced cell death at 100 uM after 36 hrs by CellTiter-Glo luminescent cell viability assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis.
AID1565065Antiviral activity against Influenza A virus A/Victoria/361/2011(H3N2) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID1637797Inhibition of Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) M2 V27A/S31N double mutant expressed in yeast cells after 46 to 48 hrs2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID524849Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po bid administered 11 hrs post infection for 5 days before infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1301448Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in dog MDCK cells preincubated with virus for 15 mins followed by cells addition measured at 36 hrs post infection2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
AID1820896Antiviral activity against Influenza A virus A/WSN/33(H1N1) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID648648Cytotoxicity against MDCK cells2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID1222582Drug uptake in Pichia pastoris GS115 expressing mouse recombinant PEPT1 at 5 uM after 0.5 to 5 mins by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID525056Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered QD post 13 hrs infection measured after 37 hrs po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID525079Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 110 mg/kg, po for 1 days before infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID531377AUC (0 to infinity) in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1484597Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells at 50 uM preincubated for 15 mins measured after 1.5 days by CellTiter-Glo assay relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Identification of new anti-inflammatory agents based on nitrosporeusine natural products of marine origin.
AID531355AUC (0 to last) in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531357Half life in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525058Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered QD post 13 hrs infection measured after 85 hrs po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID531361Apparent oral clearance in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531369Clast in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1785785Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as s reduction in virus-induced cytopathic effect after 40 hrs incubation by CellTiter-Glo assay2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID531372AUC (0 to last) in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525086Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po for 4 days post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1222580Inhibition of rat recombinant PEPT1 expressed in Pichia pastoris GS115 assessed as [3H]GlySar uptake after 30s by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531379Ratio of AUC (0 to last) in healthy adult CSF to AUC (0 to last) in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1785793Antiviral activity against Influenza A virus (A/Hong Kong/4801/2014 (H3N2)) infected in cells assessed as reduction in infected cells2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID1222586Drug uptake in Pichia pastoris GS115 expressing rat recombinant PEPT1 at 0 degC measured immediately after drug addition by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID1820904Inhibition of Influenza A virus RNA dependent RNA polymerase activity in HEK293T cells co-transfected with pPoll/NP(0)GFP(0) at 10 to 40 uM after 2 hrs post-transfection followed by compound addition incubated for 22 hrs by fluorescence microscopic analys2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID524853Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as reduction in viral titer in lung at 1 mg/kg, po bid repeated regimen after 11 hrs post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1820900Antiviral activity against Influenza A virus A/California/7/2009(H1N1) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID1610459Cytotoxicity against dog MDCK cells assessed as cell viability measured after 45 hrs by Celltiter-Glo luminescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
AID1545070Inhibition of influenza A virus chicken/Nakorn-Patom/Thailand/CU-K2-2004 Neuraminidase N1 at pH 7.4 by DIANA assay2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1.
AID1610462Antiviral activity against oseltamivir resistant Victoria lineage of Influenza B virus (B/Brisbane/60/2008) BX-35 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
AID531365Cmax in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID722600Cmax in Sprague-Dawley rat at 10 mg/kg, po2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID722349Volume of distribution at steady state in Sprague-Dawley rat at 10 mg/kg, iv2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID525057Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered QD post 13 hrs infection measured after 61 hrs po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID525089Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 11 mg/kg, po for 7 days post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1637798Toxicity against yeast assessed as reduction in cell viability2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID1785787Selectivity ratio of CC50 for MDCK cells to IC50 for Influenza A virus A/WSN/33(H1N1) infected in MDCK cells2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1820901Antiviral activity against Influenza A virus A/Aichi/8/68(H3N2) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID722355Tmax in Sprague-Dawley rat at 10 mg/kg, po2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID531368Clast in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525063Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered 13 hrs post infection, qd measured2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID525087Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po for 1 day post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1222583Drug uptake in Pichia pastoris GS115 expressing rat recombinant PEPT1 at 5 uM after 0.5 to 5 mins by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID1820899Antiviral activity against Influenza A virus A/Virginia/ATCC2/2009(H1N1) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID1711585Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as s reduction in cytopathic effect after 40 hrs incubation by CellTiter-Glo assay2016European journal of medicinal chemistry, Mar-03, Volume: 110Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
AID1484598Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells preincubated for 1 hr followed by compound wash measured after 48 hrs by plaque reduction assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Identification of new anti-inflammatory agents based on nitrosporeusine natural products of marine origin.
AID531353Tlast in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531374Half life in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531376AUC (0 to infinity) in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1565067Antiviral activity against Influenza B virus B/Sichuan/531/2018(BV) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID722350Clearance in Sprague-Dawley rat at 10 mg/kg, iv2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID722354Terminal half life in Sprague-Dawley rat at 10 mg/kg, po2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID531358AUC (0 to infinity) in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525091Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 11 mg/kg, po for 1 day post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID525088Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po for 12 hrs post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID648646Antiinfluenza activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID531375Half life in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1222584Drug uptake in Pichia pastoris GS115 expressing human recombinant PEPT1 at 0 degC measured immediately after drug addition by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID1565063Antiviral activity against Influenza A virus A/WSN/33 assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID531370Tlast in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1637795Antiviral activity against amantadine-sensitive Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) infected in MDCK cells after 40 mins by crystal violet staining-based plaque reduction assay2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID531378Ratio of Cmax in healthy adult CSF to Cmax in healthy adult plasma assessed as oseltamivir carboxylate at 150 mg, po administered as single dose2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525055Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered QD post 13 hrs infection measured after 85 hrs p2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1711584Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as s reduction in cytopathic effect after 40 hrs incubation by CellTiter-Glo assay relative to control2016European journal of medicinal chemistry, Mar-03, Volume: 110Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
AID1785794Antiviral activity against Influenza B virus (B/Sichuan/531/2018(Victoria)) infected in cells assessed as reduction in infected cells2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID1129833Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate at 100 uM after 30 mins2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
AID531351Clast in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID531346Cmax in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1222589Stability in Pichia pastoris GS115 expressing rat recombinant PEPT1 at 5 uM measured for up to 30 mins by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID1565068Antiviral activity against Influenza B virus B/Massachusetts/2/2012(BV) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID525066Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered 13 hrs post infection, qd measured 2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID531356Half life in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID648649Selectivity index, ratio of TC50 for MDCK cells to IC50 for influenza A virus H3N22012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID648650Selectivity index, ratio of TC50 for MDCK cells to IC50 for influenza A virus H1N12012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID531347Cmax in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525080Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 110 mg/kg, po for 12 hrs before infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1820902Antiviral activity against Influenza A virus B/Lee/40(type B) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay2022Journal of medicinal chemistry, 01-13, Volume: 65, Issue:1
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
AID1637792Cytotoxicity against MDCK cells assessed as reduction in cell viability after 24 hrs by MTT assay2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID531354AUC (0 to last) in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1180485Antiviral activity against Influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as inhibition of virus-induced cell death after 36 hrs by CellTiter-Glo luminescent cell viability assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis.
AID525059Half life in rat assessed as oseltamivir carboxylate2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1610461Antiviral activity against Influenza A virus A/Texas/50/2012(H3N2) infected in MDCK cells inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
AID1222567Stability in Pichia pastoris GS115 at 5 uM measured for up to 30 mins by HPLC analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531362Ratio of Cmax in healthy adult CSF to Cmax in healthy adult plasma at 150 mg, po administered as single dose2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID722611Terminal half life in Sprague-Dawley rat at 10 mg/kg, iv2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID531349Tmax in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525082Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po bid administered 11 hrs post infection for 5 days before infection measured on day 202010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1711586Cytotoxicity against MDCK cells after 40 hrs incubation by CellTiter-Glo assay2016European journal of medicinal chemistry, Mar-03, Volume: 110Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
AID531373AUC (0 to last) in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1637796Inhibition of wild type Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) M2 expressed in yeast cells after 46 to 48 hrs2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID1222564Protein binding in human at 50 to 500 mg, po bid2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID722351Oral bioavailability in Sprague-Dawley rat at 10 mg/kg2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
AID1637794Antiviral activity against amantadine-resistant Influenza A virus (A/chicken/Hubei/327/2004(H5N1)) infected in MDCK cells after 40 mins by crystal violet staining-based plaque reduction assay2019MedChemComm, Jan-01, Volume: 10, Issue:1
Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus.
AID648647Antiinfluenza activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID1545068Inhibition of Influenza A virus (A/California/07/2009(H1N1)) Neuraminidase N1 at pH 7.4 by DIANA assay2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1.
AID525064Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered 13 hrs post infection, qd measured2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID524867Antimicrobial activity against oseltamivir-sensitive influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 1 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered QD post 13 hrs infection measured after 61 hrs p2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID531359AUC (0 to infinity) in healthy adult CSF at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID531350Clast in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1565066Antiviral activity against Influenza B virus B/Yamagata/16/88(BY) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 40 hrs by Celltiter-Glo assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.
AID1129834Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins2014Bioorganic & medicinal chemistry, Apr-01, Volume: 22, Issue:7
Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
AID525085Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as increase in mouse survival at 1.1 mg/kg, po for 7 days post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1785791Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect at 100 uM measured after 40 hrs incubation by inverted microscpic imaging analysis2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID525067Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered 13 hrs post infection, qd measured 2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID524852Antimicrobial activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po bid repeated regimen after 11 hrs post infection2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID524859Antimicrobial activity against Influenza B virus (B/Malaysia/2506/2004) infected po dosed Mustela putorius furo assessed as nasal viral titer treated bid after 4 hrs post infection measured after 3 days2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID524858Antimicrobial activity against Influenza B virus (B/Malaysia/2506/2004) infected po dosed Mustela putorius furo assessed as nasal viral titer treated bid after 4 hrs post infection measured after 2 days2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1785786Cytotoxicity against MDCK cells assessed as reduction in cell viability by CellTiter-Glo assay2021ACS medicinal chemistry letters, Nov-11, Volume: 12, Issue:11
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.
AID648645Antiinfluenza activity against influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 36 hrs2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and anti-influenza activity of aminoalkyl rupestonates.
AID1222579Inhibition of mouse recombinant PEPT1 expressed in Pichia pastoris GS115 assessed as [3H]GlySar uptake after 30s by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531371Tlast in healthy adult CSF assessed as oseltamivir carboxylate at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID1222585Drug uptake in Pichia pastoris GS115 expressing mouse recombinant PEPT1 at 0 degC measured immediately after drug addition by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID531348Tmax in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID524857Antimicrobial activity against Influenza B virus (B/Malaysia/2506/2004) infected po dosed Mustela putorius furo assessed as nasal viral titer treated bid after 4 hrs post infection measured after 1 day2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1222578Inhibition of human recombinant PEPT1 expressed in Pichia pastoris GS115 assessed as [3H]GlySar uptake after 30s by dual-channel liquid scintillation counting analysis2012Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 40, Issue:7
Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.
AID1697376Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in mouse assessed as reduction in viral titer in lung by measuring reduction in virus infectivity in MDCK cells at 5 mg/kg, po administered after 5 days of infection and measured aft2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor.
AID525065Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 1.0 mg/kg, po administered 13 hrs post infection, qd measured2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID531352Tlast in healthy adult plasma at 150 mg, po administered as single dose by LC/MS analysis2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.
AID525068Antimicrobial activity against H274Y mutant oseltamivir-resistant influenza A virus (A/Yokohama/67/2006 (H1N1)) clone 11 infected in BALB/c mouse assessed as reduction in viral titer in lung at 10 mg/kg, po administered 13 hrs post infection, qd measured 2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1610460Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect measured after 45 hrs by CellTiter-Glo luminescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.56)29.6817
2010's14 (77.78)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 120.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index120.50 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index225.66 (26.88)
Search Engine Supply Index2.10 (0.95)

This Compound (120.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]